ofloxacin has been researched along with Bacterial Skin Diseases in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (40.91) | 18.2507 |
2000's | 11 (50.00) | 29.6817 |
2010's | 2 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chatterjee, D; Dabas, G; Dogra, S; Narang, T; Sharma, K; Sharma, M | 1 |
Blatun, LA; Terekhova, RP | 1 |
Iwasawa, MT; Kambe, N; Matsue, H; Ohkusu, K; Ota, R | 1 |
Fujita, N; Hatamochi, A; Kakuta, M; Matsumoto, F; Matsushima, H; Shinkai, H; Utani, A | 1 |
Bormann, G; Marsch, WC | 1 |
Blatun, LA; Iakovlev, VP; Svetukhin, AM; Ukhin, SA | 1 |
Ishii, M; Nakagawa, K; Tsuruta, D | 1 |
Graybill, JR; Moreno, F; Valero, G | 1 |
Gentry, LO; Rodriguez-Gomez, G | 1 |
Bolash, NK; Liu, HH; Lynch, RA; McAnany, ME | 1 |
Iijima, S; Otsuka, F; Saito, J | 1 |
Berman, AL; Chow, AT; Corrado, M; Dornseif, B; Drusano, GL; Fowler, CL; Natarajan, J; Preston, SL; Reichl, V | 1 |
Jasovich, A; Neto, W; Nicodemo, AC; Robledo, JA | 1 |
Akiyama, H; Arata, J; Kanzaki, H; Tada, J; Yamasaki, O | 1 |
Fridolijn Jongevos, S; Habets, JM; Prens, EP | 1 |
de Jong, JJ; Endtz, HP; IJzermans, JN; van Gelder, T; Weimar, W | 1 |
Rajacic, Z; Trampuz, A; Wenk, M; Zimmerli, W | 1 |
Hooper, DC | 1 |
Ballester, B; Del Pozo, JL; Hernáez, S; Lecároz, C; Leiva, J | 1 |
Garvin, CG; Jung, R; Martin, SJ | 1 |
Breen, JD; Brown, MJ; Champlin, J; Jones, TM; Miskin, BM; Tarshis, GA; Wingert, KJ | 1 |
Blondeau, JM | 1 |
5 review(s) available for ofloxacin and Bacterial Skin Diseases
Article | Year |
---|---|
[Levofloxacin in complex therapy of patients with skin and soft tissue infections].
Topics: Anti-Bacterial Agents; Humans; Levofloxacin; Ofloxacin; Skin Diseases, Bacterial; Soft Tissue Infections | 2008 |
[Modern fluoroquinolones (ciprofoxacin, levofloxacin) and the treatment of skin and soft tissue infections].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Ciprofloxacin; Gastrointestinal Diseases; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Skin Diseases; Skin Diseases, Bacterial; Soft Tissue Infections; Urea | 2004 |
The fluoroquinolones after ciprofloxacin and ofloxacin.
Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Naphthyridines; Ofloxacin; Piperazines; Respiratory Tract Infections; Sexually Transmitted Diseases, Bacterial; Skin Diseases, Bacterial; Urinary Tract Infections | 2000 |
A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Microbial; Drug-Related Side Effects and Adverse Reactions; Humans; Levofloxacin; Ofloxacin; Respiratory Tract Infections; Risk Assessment; Skin Diseases, Bacterial; Urinary Tract Infections | 2001 |
The role of fluoroquinolones in skin and skin structure infections.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Skin Diseases, Bacterial; Staphylococcus aureus; Streptococcus | 2002 |
5 trial(s) available for ofloxacin and Bacterial Skin Diseases
Article | Year |
---|---|
Ofloxacin treatment of difficult infections of the skin and skin structure.
Topics: Abscess; Administration, Oral; Adult; Aged; Aged, 80 and over; Cellulitis; Drug Administration Schedule; Enterobacteriaceae Infections; Humans; Injections, Intravenous; Middle Aged; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Remission Induction; Risk Factors; Skin Diseases, Bacterial; Skin Ulcer; Staphylococcal Infections; Superinfection; Surgical Wound Infection; Treatment Failure | 1993 |
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.
Topics: Adolescent; Adult; Anti-Infective Agents; Bacteria; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Ofloxacin; Skin Diseases, Bacterial; Soft Tissue Infections | 1995 |
Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials.
Topics: Adult; Anti-Infective Agents; Area Under Curve; Bacterial Infections; Bayes Theorem; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Levofloxacin; Logistic Models; Male; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections | 1998 |
A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Skin Diseases, Bacterial; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome | 1998 |
Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcus aureus; Treatment Outcome | 2001 |
12 other study(ies) available for ofloxacin and Bacterial Skin Diseases
Article | Year |
---|---|
Cutaneous non-tubercular mycobacterial infection in pregnancy and treatment consideration.
Topics: Adult; Anti-Bacterial Agents; Female; Humans; Linezolid; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Pregnancy; Pregnancy Complications, Infectious; Skin; Skin Diseases, Bacterial | 2019 |
Maximum growth temperature test for cutaneous Mycobacterium chelonae predicts the efficacy of thermal therapy.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Hyperthermia, Induced; Male; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Neutrophil Infiltration; Ofloxacin; Prednisolone; Skin Diseases, Bacterial; Treatment Outcome | 2012 |
Levofloxacin alone efficiently treated a cutaneous mycobacterium fortuitum infection.
Topics: Administration, Oral; Adolescent; Anti-Infective Agents; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Skin Diseases, Bacterial; Treatment Outcome | 2002 |
[Sporotrichoid atypical mycobacterial infections. Antibiotic monotherapy].
Topics: Adult; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Female; Forearm; Hand Dermatoses; Humans; Levofloxacin; Lymphadenitis; Male; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Ofloxacin; Skin; Skin Diseases, Bacterial; Sporotrichosis; Treatment Outcome | 2004 |
Successful treatment of a widespread cutaneous Mycobacterium fortuitum infection with levofloxacin.
Topics: Adult; Anti-Bacterial Agents; Female; Humans; Levofloxacin; Mycobacterium; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Skin Diseases, Bacterial; Treatment Outcome | 2006 |
Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection.
Topics: Animals; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycobacterium; Ofloxacin; Skin Diseases, Bacterial; Splenic Diseases | 1994 |
Mycobacterium marinum skin infection successfully treated with levofloxacin.
Topics: Adult; Anti-Infective Agents; Humans; Levofloxacin; Male; Mycobacterium Infections, Nontuberculous; Ofloxacin; Remission Induction; Skin Diseases, Bacterial | 1997 |
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Erythromycin; Fluoroquinolones; Fusidic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillins; Skin Diseases, Bacterial; Species Specificity; Streptococcal Infections; Streptococcus; Vancomycin | 1999 |
Successful triple-antibiotic therapy for cutaneous infection due to Mycobacterium chelonae.
Topics: Aged; Doxycycline; Drug Therapy, Combination; Ethambutol; Female; Humans; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ofloxacin; Skin; Skin Diseases, Bacterial | 1999 |
Atypical mycobacterium infection with dermatological manifestation in a renal transplant recipient.
Topics: Clarithromycin; Drug Therapy, Combination; Ethambutol; Foot; Humans; Kidney Transplantation; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Postoperative Complications; Rifampin; Skin Diseases, Bacterial | 1999 |
Pharmacokinetics and pharmacodynamics of levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid.
Topics: Anti-Infective Agents; Blister; Body Fluids; Granulocytes; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pneumococcal Infections; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors | 2000 |
[Recurrent abscesses in a renal transplant recipient].
Topics: Abscess; Drug Therapy, Combination; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Nocardia asteroides; Nocardia Infections; Ofloxacin; Opportunistic Infections; Postoperative Complications; Recurrence; Skin Diseases, Bacterial; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |